NeoVax With Nivolumab in Patients With Ovarian Cancer
Clinical trial NCT04024878 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04024878
- Sponsor
- Dana-Farber Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-20
- Primary completion
- 2025-04-30
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.